AIRLINK 78.39 Increased By ▲ 5.39 (7.38%)
BOP 5.34 Decreased By ▼ -0.01 (-0.19%)
CNERGY 4.33 Increased By ▲ 0.02 (0.46%)
DFML 30.87 Increased By ▲ 2.32 (8.13%)
DGKC 78.51 Increased By ▲ 4.22 (5.68%)
FCCL 20.58 Increased By ▲ 0.23 (1.13%)
FFBL 32.30 Increased By ▲ 1.40 (4.53%)
FFL 10.22 Increased By ▲ 0.16 (1.59%)
GGL 10.29 Decreased By ▼ -0.10 (-0.96%)
HBL 118.50 Increased By ▲ 2.53 (2.18%)
HUBC 135.10 Increased By ▲ 2.90 (2.19%)
HUMNL 6.87 Increased By ▲ 0.19 (2.84%)
KEL 4.17 Increased By ▲ 0.14 (3.47%)
KOSM 4.73 Increased By ▲ 0.13 (2.83%)
MLCF 38.67 Increased By ▲ 0.13 (0.34%)
OGDC 134.85 Increased By ▲ 1.00 (0.75%)
PAEL 23.40 Decreased By ▼ -0.43 (-1.8%)
PIAA 26.64 Decreased By ▼ -0.49 (-1.81%)
PIBTL 7.02 Increased By ▲ 0.26 (3.85%)
PPL 113.45 Increased By ▲ 0.65 (0.58%)
PRL 27.73 Decreased By ▼ -0.43 (-1.53%)
PTC 14.60 Decreased By ▼ -0.29 (-1.95%)
SEARL 56.50 Increased By ▲ 0.08 (0.14%)
SNGP 66.30 Increased By ▲ 0.50 (0.76%)
SSGC 10.94 Decreased By ▼ -0.07 (-0.64%)
TELE 9.15 Increased By ▲ 0.13 (1.44%)
TPLP 11.67 Decreased By ▼ -0.23 (-1.93%)
TRG 71.43 Increased By ▲ 2.33 (3.37%)
UNITY 24.51 Increased By ▲ 0.80 (3.37%)
WTL 1.33 No Change ▼ 0.00 (0%)
BR100 7,493 Increased By 58.6 (0.79%)
BR30 24,558 Increased By 338.4 (1.4%)
KSE100 72,052 Increased By 692.5 (0.97%)
KSE30 23,808 Increased By 241 (1.02%)
Brecorder Logo
Apr 25, 2024 اردو ► PRINT EDITION ► BR MARKETS ► Dollar to PKR ►

AstraZeneca vaccines

AstraZeneca says EU loses legal bid for more vaccine supplies by end-June
World

AstraZeneca says EU loses legal bid for more vaccine supplies by end-June

  • The supply cuts delayed the EU's vaccination drive in the first quarter of the year, when the bloc had initially bet on AstraZeneca to deliver the largest volume of its shots.
  • The court said in a statement that AstraZeneca must deliver 15 million doses by July 26, another 20 million by Aug. 23 and another 15 million by Sept. 27, for a total of 50 million doses.
Published 18 Jun, 2021 06:10pm
Britain approves J&J COVID-19 vaccine for use
World

Britain approves J&J COVID-19 vaccine for use

  • Britain also cut its order for the single-dose shot, also known as J&J unit Janssen's vaccine, amid issues with the company's supply chain and reports of rare blood clots.
  • J&J's vaccine is already approved in the United States and European Union, where reports of rare blood clots are being reviewed.
Published 28 May, 2021 05:36pm
Japan health panel approves Moderna, AstraZeneca COVID-19 vaccines
World

Japan health panel approves Moderna, AstraZeneca COVID-19 vaccines

  • The recommendations by a health ministry panel precede official approval by the government on Friday, national broadcaster NHK reported.
  • Supplies of the Moderna doses have already been imported and are planned for use at mass vaccination centres in Tokyo and Osaka from next week.
Published 20 May, 2021 07:37pm
South Korea suspends AstraZeneca shots for people under 60 amid European review
World

South Korea suspends AstraZeneca shots for people under 60 amid European review

  • The European Medical Agency (EMA) is due to announce the results of a review on whether some cases of blood clotting in adults may be linked to the AstraZeneca shot.
  • South Korea's food and drug safety ministry said on Wednesday it had granted final approval for Johnson & Johnson's (J&J) vaccine after a panel of experts ruled the single-dose shot was safe and effective.
Published 07 Apr, 2021 07:12pm
Ukraine approves Chinese vaccine as COVID-19 cases hit new record high
World

Ukraine approves Chinese vaccine as COVID-19 cases hit new record high

  • Ukraine received its first batch of 215,000 Sinovac doses in March to boost its vaccination programme, which has lagged behind many other European countries and it has so far relied on a single batch of AstraZeneca vaccines from India.
  • "The vaccines of the Chinese company Sinovac Biotech can be trusted," it said.
Published 03 Apr, 2021 06:41pm
Netherlands halts use of AstraZeneca vaccine for people under 60
World

Netherlands halts use of AstraZeneca vaccine for people under 60

  • The decision was made following new reports from medicine monitoring agency Lareb and discussions with health authorities, a Health Ministry statement said.
  • "Authorities in the UK, European Union, the World Health Organization have concluded that the benefits of using our vaccine to protect people from this deadly virus significantly outweigh the risks across all adult age groups," it said.
Updated 02 Apr, 2021 09:06pm